Polymorphisms of the FAS and FASL genes and risk of breast cancer. - Wikidata - awgldk - TriplyDB

Polymorphisms of the FAS and FASL genes and risk of breast cancer.

Polymorphisms of the FAS and FASL genes and risk of breast cancer.

http://www.wikidata.org/entity/Q41811141

about

Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies FAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controls FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects Association of Fas -1377 G/A polymorphism with susceptibility to cancer Association between Fas/FasL polymorphism and susceptibility to leukemia: a meta-analysis.Fas-670A>G polymorphism is not associated with an increased risk of acute myeloid leukemia development DGCA: A comprehensive R package for Differential Gene Correlation Analysis.Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population.Increased resistance to Staphylococcus aureus endophthalmitis in BALB/c mice: Fas ligand is required for resolution of inflammation but not for bacterial clearance.Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese females.FAS and FASL gene polymorphisms are not associated with hepatitis B virus infection based on a case-control study in a Brazilian population.FasL gene -844T/C mutation of esophageal cancer in South China and its clinical significance.

P2860

Q26859155-2064073B-13EB-4962-BB55-89269F0D12F4 Q26866492-B3D99540-5558-4824-B61A-D33A0811D924 Q28389021-09337B3A-2FED-4AFB-929D-F529F0F974F7 Q28396240-D9CAD606-F8E0-4F86-85CA-4E357432D5E8 Q35643734-265C63A6-0203-49D4-851B-21F41D5A5AC6 Q35928161-ED6F75AE-05BA-4491-B861-254502D0C007 Q36193416-CF616D78-F898-4128-8A81-3B213CF67628 Q36797318-0D3D7235-1F70-4128-8976-19175A1EAB5F Q36911426-97CAB162-9C89-43A1-B462-1E301696D67F Q37138359-9AC934C2-683F-443B-9AC3-351B0E598EA8 Q37358408-7FE3FAB4-54A5-4D03-B1D3-D0FDC6C89A5A Q37736549-00C76981-B355-422B-ABCB-E3C2CE554E67

P2860

Polymorphisms of the FAS and FASL genes and risk of breast cancer.

http://www.wikidata.org/entity/Q41811141

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Polymorphisms of the FAS and FASL genes and risk of breast cancer.

@en

type

label

Polymorphisms of the FAS and FASL genes and risk of breast cancer.

@en

prefLabel

Polymorphisms of the FAS and FASL genes and risk of breast cancer.

@en

P1433

Q41811141-39B57726-697C-443A-8A96-8618199E4378

P1476

Q41811141-C7D5DB37-160B-4511-8DFB-6F529A0493A7

P2093

Q41811141-4E7EBF7C-4572-43DD-B528-8B87A6BB75A0

Q41811141-527D47BF-A578-4DB8-AF0E-87289F5100C7

Q41811141-7EA070F6-B4CF-43B4-B552-AC979A1CDBA1

Q41811141-91666BDE-EDDF-41B7-A410-877F20784621

Q41811141-984DEAE3-F519-4FB0-BD45-7950433F9FDD

Q41811141-E2F25A49-4FF4-4D3A-9C31-395D55E074D0

P2860

Q41811141-0FC4F33C-52D4-4405-97A7-6C1FB1B42D64

Q41811141-134BC920-70BD-4F66-89DA-14E8378502E9

Q41811141-18F5F8D7-0D5F-4F69-883B-8CADCBCBFB71

Q41811141-2CFE5570-62B9-472F-8E01-36942B50FE7E

Q41811141-3AE23BCE-E708-4589-B20A-E29C725A9E88

Q41811141-3F7A40DE-FD60-468D-BD79-136A75A58DFA

Q41811141-62F408D9-F176-4013-B089-47342CF11499

Q41811141-713582DF-E59D-4B7D-B8D8-E233099AC597

Q41811141-8F5FB8A5-7863-4460-B828-12AF21516010

Q41811141-9A446D10-7CBF-4CDE-BB47-90D0CF939020

P304

Q41811141-8049594A-FC22-4441-8777-7071E5E3E53A

P31

Q41811141-27A8DAAF-3AAF-4FA0-A31A-4BB76C19CF2A

P356

Q41811141-4991AF44-6343-45FE-AD1E-4D64305BD271

P433

Q41811141-825E9E3C-3821-4F19-B9B3-5DDC437D87E1

P478

Q41811141-0E9FAD77-3D0D-4621-BD67-46604EB7F870

P577

Q41811141-650C8728-8254-4911-B56F-11409873F974

P5875

Q41811141-8D38BDF6-00CA-4E8A-9463-2D129F63B3ED

P698

Q41811141-CB9B53B2-E216-49AC-9AE5-A9D8C47BA7A0

P932

Q41811141-B69AD0E2-131D-4D61-AAA6-48822C8662E2

P356

P1433

Oncology Letters

P1476

Polymorphisms of the FAS and FASL genes and risk of breast cancer.

@en

P2093

Binbin Cui

http://www.w3.org/2001/XMLSchema#string

Feilin Cao

http://www.w3.org/2001/XMLSchema#string

Hui Lin

http://www.w3.org/2001/XMLSchema#string

Wenjie Yu

http://www.w3.org/2001/XMLSchema#string

Wenmin Wang

http://www.w3.org/2001/XMLSchema#string

Zhongqiu Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Proliferation, cell cycle and apoptosis in cancer

The Fas signaling pathway: more than a paradigm

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

The FAS ligand promoter polymorphism, rs763110 (-844C>T), contributes to cancer susceptibility: evidence from 19 case-control studies

Apoptosis in oncology.

The biological role of the Fas/FasL system during tumor formation and progression.

Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer.

The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy.

The Fas signalling pathway and its role in the pathogenesis of cancer.

The role of death receptor ligands in shaping tumor microenvironment.

P304

625-628

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2011.541

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228083061

http://www.w3.org/2001/XMLSchema#string

P698

22740964

http://www.w3.org/2001/XMLSchema#string

P932

3362490

http://www.w3.org/2001/XMLSchema#string